Literature DB >> 31916649

Silencing of lncRNA UCA1 curbs proliferation and accelerates apoptosis by repressing SIRT1 signals by targeting miR-204 in pediatric AML.

Yu Liang1,2, Erwei Li1,2, Hongliang Zhang1,2, Lina Zhang1,2, Yingying Tang1,2, Yuanyuan Wanyan1,2.   

Abstract

The long noncoding RNA urothelial carcinoma-associated 1 (UCA1) has been reported to sustain the proliferation of acute myeloid leukemia (AML) cells through downregulating cell cycle regulators p27kip1 . Yet, the foundational mechanism of UCA1 in AML pathologies remains unclear. Herein, we found an escalation of UCA1 expression and suppression of miR-204 expression in pediatric AML patients and cells. UCA1 silencing suppressed cell proliferative abilities, promoted apoptotic rates, decreased Ki67, and increased cleaved caspase-3 in AML cells. Moreover, UCA1 sponged miR-204 and suppressed its expression. UCA1 overexpression inversed the miR-204 suppressed proliferation and promoted apoptosis. UCA1 also boosted the expression of SIRT1, a miR-204 target, via the sponging interaction. Furthermore, miR-204 inhibited inducible nitric oxide synthase and cyclooxygenase-2 expression, while UCA1 overexpression inversed the inhibitory effects in AML cells. Our findings concluded that UCA1 downregulation repressed cell proliferation and promoted apoptosis through inactivating SIRT1 signals by upregulating miR-204 in pediatric AML.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; lncRNA UCA1; miR-204; pediatric acute myeloid leukemia; proliferation

Year:  2020        PMID: 31916649     DOI: 10.1002/jbt.22435

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  7 in total

Review 1.  Long noncoding RNAs as regulators of pediatric acute myeloid leukemia.

Authors:  Sina Neyazi; Michelle Ng; Dirk Heckl; Jan-Henning Klusmann
Journal:  Mol Cell Pediatr       Date:  2022-05-20

Review 2.  The Role of cis- and trans-Acting RNA Regulatory Elements in Leukemia.

Authors:  Irina A Elcheva; Vladimir S Spiegelman
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.639

3.  LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.

Authors:  Jiajia Li; Zhongyu Li; Xue Bai; Xiaofeng Chen; Meng Wang; Yanping Wu; Haotian Wu
Journal:  J Oncol       Date:  2022-02-08       Impact factor: 4.375

Review 4.  An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.

Authors:  Debora Bencivenga; Emanuela Stampone; Angela Vastante; Myassar Barahmeh; Fulvio Della Ragione; Adriana Borriello
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

Review 5.  Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia.

Authors:  Huan Xu; Yuxi Wen; Runming Jin; Hongbo Chen
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

Review 6.  Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs.

Authors:  Patricia de la Cruz-Ojeda; Rocío Flores-Campos; Sandra Dios-Barbeito; Elena Navarro-Villarán; Jordi Muntané
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

7.  Knockdown of lncRNA HOXA-AS3 Suppresses the Progression of Atherosclerosis via Sponging miR-455-5p.

Authors:  Kui Chi; Jinwen Zhang; Huanhuan Sun; Yang Liu; Ye Li; Tao Yuan; Feng Zhang
Journal:  Drug Des Devel Ther       Date:  2020-09-09       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.